Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytoplasmic Dyneins | 1 | 2018 | 27 | 0.350 |
Why?
|
| DNA | 3 | 2018 | 7084 | 0.350 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 82 | 0.320 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2017 | 148 | 0.300 |
Why?
|
| BRCA1 Protein | 2 | 2018 | 1042 | 0.270 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2017 | 580 | 0.260 |
Why?
|
| Genes, BRCA1 | 1 | 2018 | 759 | 0.260 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 9730 | 0.230 |
Why?
|
| BRCA2 Protein | 2 | 2016 | 702 | 0.230 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2014 | 471 | 0.200 |
Why?
|
| Nuclear Proteins | 4 | 2019 | 5933 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2017 | 2879 | 0.190 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 1690 | 0.170 |
Why?
|
| Food, Fortified | 1 | 2019 | 189 | 0.170 |
Why?
|
| Protein Binding | 5 | 2018 | 9555 | 0.160 |
Why?
|
| DNA Replication | 1 | 2014 | 1419 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2019 | 327 | 0.150 |
Why?
|
| Micronutrients | 1 | 2019 | 367 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2019 | 11942 | 0.140 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 899 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 712 | 0.130 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 4748 | 0.120 |
Why?
|
| DNA Damage | 3 | 2018 | 2429 | 0.120 |
Why?
|
| Poverty Areas | 1 | 2013 | 260 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2017 | 3211 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2019 | 2538 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 1336 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 2938 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2983 | 0.090 |
Why?
|
| Eye Diseases | 1 | 2013 | 654 | 0.080 |
Why?
|
| Platinum | 1 | 2018 | 218 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3140 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 16726 | 0.070 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 184 | 0.070 |
Why?
|
| Nepal | 2 | 2019 | 276 | 0.070 |
Why?
|
| Fanconi Anemia | 1 | 2017 | 319 | 0.070 |
Why?
|
| Leishmania infantum | 1 | 2014 | 18 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 3946 | 0.060 |
Why?
|
| Genomic Instability | 1 | 2018 | 687 | 0.060 |
Why?
|
| Phthalazines | 1 | 2016 | 357 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2017 | 1769 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 672 | 0.060 |
Why?
|
| Lysine | 1 | 2017 | 1025 | 0.060 |
Why?
|
| Ubiquitination | 1 | 2017 | 989 | 0.060 |
Why?
|
| Chromatin | 2 | 2019 | 2678 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 5190 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 1805 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 494 | 0.050 |
Why?
|
| Benzimidazoles | 1 | 2016 | 876 | 0.050 |
Why?
|
| Protein Transport | 1 | 2016 | 2051 | 0.050 |
Why?
|
| Powders | 1 | 2019 | 83 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2806 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1702 | 0.040 |
Why?
|
| ROC Curve | 1 | 2016 | 3521 | 0.040 |
Why?
|
| Myometrium | 1 | 2019 | 182 | 0.040 |
Why?
|
| Binding Sites | 1 | 2017 | 6210 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3631 | 0.040 |
Why?
|
| RNA Interference | 1 | 2017 | 2975 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4263 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 310 | 0.040 |
Why?
|
| DNA Repair | 1 | 2017 | 2031 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2019 | 23705 | 0.040 |
Why?
|
| Cell Line | 2 | 2019 | 16559 | 0.040 |
Why?
|
| Endometrium | 1 | 2019 | 407 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 20066 | 0.040 |
Why?
|
| Piperazines | 1 | 2016 | 2527 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6727 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 8647 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 2998 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 14154 | 0.030 |
Why?
|
| Mutation | 2 | 2018 | 29253 | 0.030 |
Why?
|
| Visually Impaired Persons | 1 | 2013 | 78 | 0.030 |
Why?
|
| Refraction, Ocular | 1 | 2013 | 177 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2013 | 128 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19892 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3681 | 0.030 |
Why?
|
| Humans | 8 | 2019 | 715594 | 0.020 |
Why?
|
| Female | 6 | 2019 | 377052 | 0.020 |
Why?
|
| Mothers | 1 | 2019 | 2021 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1714 | 0.020 |
Why?
|
| Cell Movement | 1 | 2019 | 5387 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9838 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 23385 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Infant | 2 | 2019 | 34561 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 40889 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13619 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8560 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9494 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 169173 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58293 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18175 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 212237 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 162392 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 80270 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 214639 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 41184 | 0.010 |
Why?
|
| Male | 2 | 2019 | 350143 | 0.010 |
Why?
|
| Child | 1 | 2013 | 74413 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 85064 | 0.000 |
Why?
|
Concepts
(100)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_